Biapenem/RPX 7009

Drug Profile

Biapenem/RPX 7009

Alternative Names: RPX2003/RPX7009; RPX7009/biapenem; RPX7009/RPX2003

Latest Information Update: 14 Apr 2016

Price : $50

At a glance

  • Originator Rempex Pharmaceuticals
  • Class Antibacterials; Carbapenems; Small molecules
  • Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Gram-negative infections

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top